[1]
V. Gupta and J. Gupta, “Formulation and in-vitro anticancer activity of nilotinib immediate release and ibrutinib sustained release pellets”, J. Appl. Pharm. Res., vol. 12, no. 4, pp. 31-43, Aug. 2024.